Being insulin-treated is one of the requirements for typical CGM devices like DexCom's G6, and not all of those with type 2 diabetes meet this condition. So DexCom's patient population is ...

The technology offers users more personalized tips, recommendations and education related to diet, exercise and sleep. The Stelo app then contextualizes these findings for the user. According to a ...

Dexcom received FDA clearance in March for the first over-the-counter glucose monitor, called Stelo. It’s cleared for adults who don’t take insulin, including people with Type 2 diabetes. The wellness ...

The applications of generative artificial intelligence (GenAI) have reached continuous glucose monitoring after DexCom launched rolled out the technology into its glucose biosensor products.

Investors with a lot of money to spend have taken a bearish stance on DexCom DXCM. And retail traders should know. We noticed this today when the trades showed up on publicly available options ...

Wells Fargo notes Abbott (ABT) and DexCom (DXCM) have disclosed that on December 20, they settled and entered into a cross-license agreement to resolve all outstanding patent litigation in the U.S ...

North Chicago-based Abbott announced last month it reached a settlement agreement with Dexcom over all outstanding patent disputes relating to their glucose monitoring products, which estimate ...

The FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM) device that does not need a prescription, which can be used by diabetics on oral medications, as well as non ...